Literature DB >> 25634400

Diastolic dysfunction characterizes cirrhotic cardiomyopathy.

Piyush O Somani1, Qais Contractor2, Ajay S Chaurasia3, Pravin M Rathi4.   

Abstract

AIM: Present study aims to study the occurrence of cirrhotic cardiomyopathy and its correlation to hepatorenal syndrome by assessing the cardiac status in patients with cirrhosis of liver and healthy controls.
METHODS: Thirty alcoholic cirrhotic, thirty non-alcoholic cirrhotic and thirty controls were enrolled for the study. Cardiac parameters were assessed by color doppler echocardiography. Patients were followed up for twelve months period for development of hepatorenal syndrome.
RESULTS: Mild diastolic dysfunction was present in 18 cirrhotic patients (30%): grade I in fifteen patients and grade II in three. Diastolic dysfunction was unrelated to age; sex and etiology of cirrhosis. Among all the echocardiographic parameters, only deceleration time was found to be statistically significant. Echocardiographic parameters in systolic and diastolic function were not different in compensated vs decompensated patients in different Child-Pugh classes or cirrhosis aetiologies. At one year follow-up, no significant differences were found in survival between patients with or without diastolic dysfunction. Hepatorenal syndrome developed in only two patients and its correlation with diastolic dysfunction was not statistically significant.
CONCLUSIONS: Present study shows that although diastolic dysfunction is a frequent event in cirrhosis, it is usually of mild degree and does not correlate with severity of liver dysfunction. There are no significant differences in echocardiographic parameters between alcoholic and non-alcoholic cirrhosis. HRS is not correlated to diastolic dysfunction in cirrhotic patients. There is no difference in survival at one year between patients with or without diastolic dysfunction. Diastolic dysfunction in cirrhosis is unrelated to circulatory dysfunction, ascites and HRS.
Copyright © 2014 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiomyopathy; Cirrhosis; Cirrhotic cardiomyopathy; Diastolic dysfunction

Mesh:

Year:  2014        PMID: 25634400      PMCID: PMC4310959          DOI: 10.1016/j.ihj.2014.06.001

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


  25 in total

1.  Cirrhotic cardiomyopathy: Indian scenario.

Authors:  Jacob Alexander; Peeyush Mishra; Nutan Desai; Shekhar Ambadekar; Bharat Gala; Prabha Sawant
Journal:  J Gastroenterol Hepatol       Date:  2007-03       Impact factor: 4.029

Review 2.  Cardiac electrophysiological abnormalities in patients with cirrhosis.

Authors:  Andrea Zambruni; Franco Trevisani; Paolo Caraceni; Mauro Bernardi
Journal:  J Hepatol       Date:  2006-01-24       Impact factor: 25.083

Review 3.  Recommendations for the evaluation of left ventricular diastolic function by echocardiography.

Authors:  Sherif F Nagueh; Christopher P Appleton; Thierry C Gillebert; Paolo N Marino; Jae K Oh; Otto A Smiseth; Alan D Waggoner; Frank A Flachskampf; Patricia A Pellikka; Arturo Evangelista
Journal:  J Am Soc Echocardiogr       Date:  2009-02       Impact factor: 5.251

Review 4.  Cirrhotic cardiomyopathy.

Authors:  Enrico M Zardi; Antonio Abbate; Domenico Maria Zardi; Aldo Dobrina; Domenico Margiotta; Benjamin W Van Tassell; Benjamin W Van Tassel; Antonella Afeltra; Arun J Sanyal
Journal:  J Am Coll Cardiol       Date:  2010-08-10       Impact factor: 24.094

Review 5.  Cirrhotic cardiomyopathy.

Authors:  Søren Møller; Jens H Henriksen
Journal:  J Hepatol       Date:  2010-03-31       Impact factor: 25.083

6.  Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites.

Authors:  A Krag; F Bendtsen; J H Henriksen; S Møller
Journal:  Gut       Date:  2010-01       Impact factor: 23.059

7.  Relationship between natriuretic peptides and echocardiography parameters in patients with poorly regulated type 2 diabetes.

Authors:  Magnus Dencker; Martin Stagmo; Mozhgan Dorkhan
Journal:  Vasc Health Risk Manag       Date:  2010-06-01

Review 8.  Cirrhotic cardiomyopathy.

Authors:  Saleh A Alqahtani; Tamer R Fouad; Samuel S Lee
Journal:  Semin Liver Dis       Date:  2008-02       Impact factor: 6.115

9.  The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt.

Authors:  Rania Nancy Rabie; Massimo Cazzaniga; Francesco Salerno; Florence Wong
Journal:  Am J Gastroenterol       Date:  2009-06-16       Impact factor: 10.864

Review 10.  Cardiovascular complications of cirrhosis.

Authors:  S Møller; J H Henriksen
Journal:  Gut       Date:  2008-02       Impact factor: 23.059

View more
  7 in total

1.  Prevalence and clinical presentation of cirrhotic cardiomyopathy: A single centre experience from southern India.

Authors:  Ravi Bokarvadia; Mayank Jain; Chandankumar Kedarisetty; Joy Varghese; Jayanthi Venkataraman
Journal:  Indian J Gastroenterol       Date:  2019-05-21

2.  Cirrhotic cardiomyopathy is less prevalent in patients with Budd-Chiari syndrome than cirrhosis of liver.

Authors:  Akash Shukla; Pratin Bhatt; Deepak Kumar Gupta; Tejas Modi; Jatin Patel; Milind Phadke; Krantikumar Rathod; Megha Meshram; S J Bhatia
Journal:  Indian J Gastroenterol       Date:  2018-01-24

3.  A Prospective Study of Prevalence and Predictors of Cirrhotic Cardiomyopathy and Its Role in Development of Hepatorenal Syndrome.

Authors:  Shrihari A Anikhindi; Piyush Ranjan; Mandhir Kumar; Rajat Mohan
Journal:  J Clin Exp Hepatol       Date:  2021-11-15

4.  Impact of Cirrhotic Cardiomyopathy Diagnosed According to Different Criteria on Patients with Cirrhosis Awaiting Liver Transplantation: A Retrospective Cohort Study.

Authors:  Achintya D Singh; Andrew Ford; Ruishen Lyu; Habib Layoun; Serge C Harb; Maan Fares; William D Carey
Journal:  Dig Dis Sci       Date:  2022-02-12       Impact factor: 3.487

5.  In HCV-related liver cirrhosis, local pulse wave velocity increases and in decompensated patients correlates with poorer survival.

Authors:  Chien-Hao Huang; Lung-Sheng Wu; Wen-Juei Jeng; Yu-Fu Cheng; Yu-Shien Ko; I-Shyan Sheen; Chun-Yen Lin
Journal:  PLoS One       Date:  2019-03-19       Impact factor: 3.240

6.  Association of N- terminal Pro Brain Natriuretic Peptide with Echocardiographic Measures of Diastolic Dysfunction in Cirrhosis.

Authors:  Ajmera Jail Singh; Mukta Wyawahare; Krishna Sarin; Soundravally Rajendiran; Dharanipragada K S Subrahmanyam; Santhosh Satheesh
Journal:  Adv Biomed Res       Date:  2020-10-30

7.  Diastolic Dysfunction Is a Predictor of Poor Survival in Patients with Decompensated Cirrhosis.

Authors:  Manas Kumar Behera; Surendra Nath Swain; Manoj Kumar Sahu; Gaurav Kumar Behera; Debakanta Mishra; Jimmy Narayan; Ayaskant Singh; Shobhit Agarwal; Pradeep Kumar Mallick
Journal:  Int J Hepatol       Date:  2021-12-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.